172 related articles for article (PubMed ID: 8083461)
21. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
22. Stinging insect allergy and venom immunotherapy.
Gupta P; Greenberger PA
Allergy Asthma Proc; 2004; 25(4 Suppl 1):S9-10. PubMed ID: 15515364
[No Abstract] [Full Text] [Related]
23. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
24. Hymenoptera sting anaphylaxis: detection and clinical significance of individual bee and wasp venoms specific IgE and IgG4 antibodies.
Ameno S; Ameno K; Fuke C; Shinohara T; Kiriu T; Kinoshita H; Ijiri I
Nihon Hoigaku Zasshi; 1993 Jun; 47(3):207-12. PubMed ID: 8345683
[TBL] [Abstract][Full Text] [Related]
25. [Intolerance of specific immunotherapy with Hymenoptera venom: jumping the hurdle with omalizumab].
Wieczorek D; Kapp A; Wedi B
Hautarzt; 2014 Sep; 65(9):791-5. PubMed ID: 25234627
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
Müller UR; Golden DB; Demarco PJ; Lockey RF
Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
[No Abstract] [Full Text] [Related]
27. A controlled trial of immunotherapy in insect hypersensitivity.
Hunt KJ; Valentine MD; Sobotka AK; Benton AW; Amodio FJ; Lichtenstein LM
N Engl J Med; 1978 Jul; 299(4):157-61. PubMed ID: 78446
[TBL] [Abstract][Full Text] [Related]
28. [Allergy to hymenoptera venoms in children].
Rancé F; Abbal M; Brémont F; Dutau G
Arch Pediatr; 1999; 6 Suppl 1():55S-60S. PubMed ID: 10191925
[TBL] [Abstract][Full Text] [Related]
29. Discontinuation of venom immunotherapy.
Golden DB
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):703-4. PubMed ID: 9802387
[No Abstract] [Full Text] [Related]
30. Human albumin causes anaphylaxis during bee venom immunotherapy.
Nakonechna A; Abuzakouk M
Ann Allergy Asthma Immunol; 2014 Jun; 112(6):559-60. PubMed ID: 24785838
[No Abstract] [Full Text] [Related]
31. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
[TBL] [Abstract][Full Text] [Related]
32. Safety of Hymenoptera venom rush immunotherapy.
Laurent J; Smiejan JM; Bloch-Morot E; Herman D
Allergy; 1997 Jan; 52(1):94-6. PubMed ID: 9062635
[TBL] [Abstract][Full Text] [Related]
33. Anaphylaxis after Hymenoptera sting without detectable specific IgE.
Zidarn M; Kosnik M; Drinovec I
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):31-3. PubMed ID: 17992452
[TBL] [Abstract][Full Text] [Related]
34. Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms.
Mingomataj E; Priftanji A; Qirko E; Dinh QT; Fischer A; Peiser C; Groneberg DA
BMC Dermatol; 2002 Aug; 2():11. PubMed ID: 12201901
[TBL] [Abstract][Full Text] [Related]
35. Gastroesophageal hymenoptera stings add to causes of idiopathic anaphylaxis.
Stoevesandt J; Grundmeier N; Trautmann A
Ann Allergy Asthma Immunol; 2012 Feb; 108(2):125-6. PubMed ID: 22289734
[No Abstract] [Full Text] [Related]
36. Jessner lymphocytic infiltrate as a side effect of bee venom immunotherapy.
Yalcin AD; Bisgin A; Akman A; Erdogan G; Ciftcioglu MA; Yegin O
J Investig Allergol Clin Immunol; 2012; 22(4):308-9. PubMed ID: 22812210
[No Abstract] [Full Text] [Related]
37. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
[TBL] [Abstract][Full Text] [Related]
38. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
39. Systemic and local reactions of bee venom immunotherapy in Iran.
Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
[TBL] [Abstract][Full Text] [Related]
40. [Bee venom immunotherapy: whom to treat with which regiment for how long?].
Díez Gómez AM
Allergol Immunopathol (Madr); 1995; 23(6):256-62. PubMed ID: 8579002
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
